162 related articles for article (PubMed ID: 21935919)
21. Association of Cholangiocarcinoma among People with Periductal Fibrosis.
Moungthard H; Thinkhamrop K; Chamadol N; Laopaiboon V; Thinkhamrop B; Kelly M
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4147-4154. PubMed ID: 38156850
[TBL] [Abstract][Full Text] [Related]
22. Plasma checkpoint protein 1 (Chk1) as a potential diagnostic biomarker for opisthorchiasis and cholangiocarcinoma.
Phanaksri T; Yingchutrakul Y; Roytrakul S; Prasopdee S; Kunjantarachot A; Butthongkomvong K; Tesana S; Sathavornmanee T; Thitapakorn V
Cancer Biomark; 2022; 33(1):43-55. PubMed ID: 34366327
[TBL] [Abstract][Full Text] [Related]
23. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis.
Loilome W; Wechagama P; Namwat N; Jusakul A; Sripa B; Miwa M; Kuver R; Yongvanit P
Parasitol Int; 2012 Mar; 61(1):136-9. PubMed ID: 21763455
[TBL] [Abstract][Full Text] [Related]
24. Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis.
Wangboon C; Yongvanit P; Loilome W; Thanan R; Worasith C; Eamudomkarn C; Chamadol N; Mairiang E; Sithithaworn J; Saichua P; Sripa B; Khuntikeo N; Bethony JM; Sithithaworn P
Am J Trop Med Hyg; 2018 Jun; 98(6):1763-1769. PubMed ID: 29637887
[TBL] [Abstract][Full Text] [Related]
25. Lipid peroxidation and etheno DNA adducts in white blood cells of liver fluke-infected patients: protection by plasma alpha-tocopherol and praziquantel.
Dechakhamphu S; Pinlaor S; Sitthithaworn P; Nair J; Bartsch H; Yongvanit P
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):310-8. PubMed ID: 20056652
[TBL] [Abstract][Full Text] [Related]
26. Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis.
Rodpai R; Luvira V; Sadaow L; Sukeepaisarnjaroen W; Kitkhuandee A; Paonariang K; Sanpool O; Ittiprasert W; Mann VH; Intapan PM; Brindley PJ; Maleewong W
Int J Infect Dis; 2022 Mar; 116():80-84. PubMed ID: 34954313
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma.
Boonjaraspinyo S; Wu Z; Boonmars T; Kaewkes S; Loilome W; Sithithaworn P; Nagano I; Takahashi Y; Yongvanit P; Bhudhisawasdi V
Parasitol Int; 2012 Mar; 61(1):145-50. PubMed ID: 21777692
[TBL] [Abstract][Full Text] [Related]
28. Plasma orosomucoid 2 as a potential risk marker of cholangiocarcinoma.
Rucksaken R; Charoensuk L; Pinlaor P; Pairojkul C; Khuntikeo N; Pinlaor S
Cancer Biomark; 2017; 18(1):27-34. PubMed ID: 27814272
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic values of parasite-specific antibody detections in saliva and urine in comparison with serum in opisthorchiasis.
Sawangsoda P; Sithithaworn J; Tesana S; Pinlaor S; Boonmars T; Mairiang E; Yongvanit P; Duenngai K; Sithithaworn P
Parasitol Int; 2012 Mar; 61(1):196-202. PubMed ID: 21704727
[TBL] [Abstract][Full Text] [Related]
30. Association between periductal fibrosis and bile duct dilatation among a population at high risk of cholangiocarcinoma: a cross-sectional study of cholangiocarcinoma screening in Northeast Thailand.
Chamadol N; Khuntikeo N; Thinkhamrop B; Thinkhamrop K; Suwannatrai AT; Kelly M; Promthet S
BMJ Open; 2019 Mar; 9(3):e023217. PubMed ID: 30898798
[TBL] [Abstract][Full Text] [Related]
31. Current State of Knowledge on Blood and Tissue-Based Biomarkers for Opisthorchis viverrini-induced Cholangiocarcinoma: A Review of Prognostic, Predictive, and Diagnostic Markers.
Kafle A; Suttiprapa S
Asian Pac J Cancer Prev; 2024 Jan; 25(1):25-41. PubMed ID: 38285765
[TBL] [Abstract][Full Text] [Related]
32. Involvement of MMP-9 in peribiliary fibrosis and cholangiocarcinogenesis via Rac1-dependent DNA damage in a hamster model.
Prakobwong S; Yongvanit P; Hiraku Y; Pairojkul C; Sithithaworn P; Pinlaor P; Pinlaor S
Int J Cancer; 2010 Dec; 127(11):2576-87. PubMed ID: 20162672
[TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori GroEL Seropositivity Is Associated with an Increased Risk of Opisthorchis viverrini-Associated Hepatobiliary Abnormalities and Cholangiocarcinoma.
Jala I; Almanfaluthi ML; Laha T; Kanthawong S; Tangkawattana S; Saichua P; Suttiprapa S; Sripa B
Korean J Parasitol; 2021 Aug; 59(4):363-368. PubMed ID: 34470087
[TBL] [Abstract][Full Text] [Related]
34. Persistent advanced periductal fibrosis is associated with cagA-positive Helicobacter pylori infection in post-praziquantel treatment of opisthorchiasis.
Phung HTT; Deenonpoe R; Suttiprapa S; Mairiang E; Edwards SW; Sripa B
Helicobacter; 2022 Aug; 27(4):e12897. PubMed ID: 35527695
[TBL] [Abstract][Full Text] [Related]
35. Spatial analysis of hepatobiliary abnormalities in a population at high-risk of cholangiocarcinoma in Thailand.
Thinkhamrop K; Suwannatrai AT; Chamadol N; Khuntikeo N; Thinkhamrop B; Sarakarn P; Gray DJ; Wangdi K; Clements ACA; Kelly M
Sci Rep; 2020 Oct; 10(1):16855. PubMed ID: 33033306
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG.
Wangboon C; Worasith C; Thanan R; Eamudomkarn C; Techasen A; Sithithaworn J; Loilome W; Chamadol N; Pinlaor S; Jumnainsong A; Yongvanit P; Khuntikeo N; Bethony JM; Sithithaworn P
Acta Trop; 2019 Jan; 189():124-128. PubMed ID: 30321522
[TBL] [Abstract][Full Text] [Related]
37. Novel Potential Biomarkers for
Aksorn N; Roytrakul S; Kittisenachai S; Leelawat K; Chanvorachote P; Topanurak S; Hamano S; Lek-Uthai U
In Vivo; 2018; 32(4):871-878. PubMed ID: 29936472
[TBL] [Abstract][Full Text] [Related]
38. Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand.
Mairiang E; Laha T; Bethony JM; Thinkhamrop B; Kaewkes S; Sithithaworn P; Tesana S; Loukas A; Brindley PJ; Sripa B
Parasitol Int; 2012 Mar; 61(1):208-11. PubMed ID: 21771664
[TBL] [Abstract][Full Text] [Related]
39. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine in patients with parasite infection and effect of antiparasitic drug in relation to cholangiocarcinogenesis.
Thanan R; Murata M; Pinlaor S; Sithithaworn P; Khuntikeo N; Tangkanakul W; Hiraku Y; Oikawa S; Yongvanit P; Kawanishi S
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):518-24. PubMed ID: 18349269
[TBL] [Abstract][Full Text] [Related]
40. High excretion of etheno adducts in liver fluke-infected patients: protection by praziquantel against DNA damage.
Dechakhamphu S; Yongvanit P; Nair J; Pinlaor S; Sitthithaworn P; Bartsch H
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1658-64. PubMed ID: 18628417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
